Search hospitals > New York > New Hyde Park
The Steven and Alexandra Cohen Children's Medical Center of New York
Claim this profileNew Hyde Park, New York 11040
Global Leader in Tumors
Global Leader in Lymphoma
Conducts research for Leukemia
Conducts research for Lymphoblastic Leukemia-Lymphoma
Conducts research for Acute Lymphoblastic Leukemia
137 reported clinical trials
8 medical researchers
Summary
The Steven and Alexandra Cohen Children's Medical Center of New York is a medical facility located in New Hyde Park, New York. This center is recognized for care of Tumors, Lymphoma, Leukemia, Lymphoblastic Leukemia-Lymphoma, Acute Lymphoblastic Leukemia and other specialties. The Steven and Alexandra Cohen Children's Medical Center of New York is involved with conducting 137 clinical trials across 342 conditions. There are 8 research doctors associated with this hospital, such as Julie Krystal, Arlene Redner, MD, Mark P Atlas, MD, and Carolyn F. Levy.Area of expertise
1Tumors
Global LeaderStage IV
Stage I
Stage II
2Lymphoma
Global LeaderStage II
Stage IV
Stage I
Top PIs
Julie KrystalThe Steven and Alexandra Cohen Children's Medical Center of New York7 years of reported clinical research
Expert in Neuroblastoma
Expert in Brain Tumor
23 reported clinical trials
38 drugs studied
Arlene Redner, MDThe Steven and Alexandra Cohen Children's Medical Center of New York4 years of reported clinical research
Studies Leukemia
Studies Lymphoblastic Leukemia-Lymphoma
11 reported clinical trials
39 drugs studied
Mark P Atlas, MDThe Steven and Alexandra Cohen Children's Medical Center of New York4 years of reported clinical research
Studies Brain Tumor
Studies Astrocytoma
10 reported clinical trials
24 drugs studied
Carolyn F. LevyThe Steven and Alexandra Cohen Children's Medical Center of New York7 years of reported clinical research
Studies Tumors
Studies Cancer
7 reported clinical trials
24 drugs studied
Clinical Trials running at The Steven and Alexandra Cohen Children's Medical Center of New York
Brain Tumor
Germ Cell Tumors
Osteosarcoma
Langerhans Cell Histiocytosis
Non-Hodgkin's Lymphoma
Astrocytoma
Neuroblastoma
Tumors
Neuroectodermal Tumors
Rhabdoid Tumor
Selumetinib + Vinblastine
for Low-Grade Glioma
This phase III trial investigates the best dose of vinblastine in combination with selumetinib and the benefit of adding vinblastine to selumetinib compared to selumetinib alone in treating children and young adults with low-grade glioma (a common type of brain cancer) that has come back after prior treatment (recurrent) or does not respond to therapy (progressive). Selumetinib is a drug that works by blocking a protein that lets tumor cells grow without stopping. Vinblastine blocks cell growth by stopping cell division and may kill cancer cells. Giving selumetinib in combination with vinblastine may work better than selumetinib alone in treating recurrent or progressive low-grade glioma.
Recruiting2 awards Phase 339 criteria
Selumetinib vs Carboplatin/Vincristine
for Brain Cancer
This phase III trial studies if selumetinib works just as well as the standard treatment with carboplatin/vincristine (CV) for subjects with NF1-associated low grade glioma (LGG), and to see if selumetinib is better than CV in improving vision in subjects with LGG of the optic pathway (vision nerves). Selumetinib is a drug that works by blocking some enzymes that low-grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs used as chemotherapy, such as carboplatin and vincristine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether selumetinib works better in treating patients with NF1-associated low-grade glioma compared to standard therapy with carboplatin and vincristine.
Recruiting2 awards Phase 328 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at The Steven and Alexandra Cohen Children's Medical Center of New York?
The Steven and Alexandra Cohen Children's Medical Center of New York is a medical facility located in New Hyde Park, New York. This center is recognized for care of Tumors, Lymphoma, Leukemia, Lymphoblastic Leukemia-Lymphoma, Acute Lymphoblastic Leukemia and other specialties. The Steven and Alexandra Cohen Children's Medical Center of New York is involved with conducting 137 clinical trials across 342 conditions. There are 8 research doctors associated with this hospital, such as Julie Krystal, Arlene Redner, MD, Mark P Atlas, MD, and Carolyn F. Levy.